Oxford Nanopore Technologies Q Line
Oxford Nanopore Technologies has launched a number of nanopore sequencing products, called Q Line, for diagnostics and other regulated markets. The Q Line products are ISO9001-qualified and allow for sequencing in a locked-down, standardized format. They are designed for water testing, veterinary diagnostics, pharmaceutical research, industrial diagnostics, forensics, and clinical research applications. The first Q Line product is the GridIon Q, a locked-down version of the GridIon sequencer with an integrated compute system. It will be available with two kits, Ligation Sequencing Kit Q and Native Barcoding Expansion Q. More Q Line products will follow, including a MinIon MK1C Q, a Flongle Q, and additional kits.
Guardant Health GuardantInform
Guardant Health has launched a clinical-genomic database service it calls GuardantInform, intended to help accelerate research and development of the next generation of cancer therapeutics. The platform offers biopharma partners de-identified longitudinal clinical information and genomic data collected from the Guardant360 liquid biopsy test, which the firm has performed on more than 100,000 samples to date.
Among potential applications, Guardant highlighted targeted drug development, clinical trial optimization, and post-marketing pharma studies. According to the company, recent data presented at the AACR virtual annual meeting further support the database's potential in these areas.
IDT gBlocks HiFi Gene Fragments
Integrated DNA Technologies has launched gBlocks HiFi Gene Fragments, double-stranded DNA fragments between 1,000 and 3,000 bp in length.
The fragments have an error rate of less than 1 in 12,000 bp and are verified with next-generation sequencing. Turnaround time is between six and 10 business days.
Applications include synthetic biology, pathway development, traditional cloning, and large construct assembly.
For more new products and services, please visit the New Products page on our website.